Sagimet Biosciences Inc (NASDAQ: SGMT) on Tuesday, plunged -8.82% from the previous trading day, before settling in for the closing price of $2.38. Within the past 52 weeks, SGMT’s price has moved between $1.73 and $7.38.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -20.00%. The company achieved an average annual earnings per share of -131.33%. With a float of $23.27 million, this company’s outstanding shares have now reached $30.67 million.
Considering the fact that the conglomerate employs 14 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Sagimet Biosciences Inc (SGMT) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Sagimet Biosciences Inc is 27.72%, while institutional ownership is 41.64%. The most recent insider transaction that took place on Jul 23 ’24, was worth 74,830. In this transaction Executive Chairman of this company sold 23,625 shares at a rate of $3.17, taking the stock ownership to the 118,693 shares. Before that another transaction happened on Jul 19 ’24, when Company’s Chief Medical Officer sold 8,357 for $3.10, making the entire transaction worth $25,910. This insider now owns 81,213 shares in total.
Sagimet Biosciences Inc (SGMT) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.88 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -131.33% per share during the next fiscal year.
Sagimet Biosciences Inc (NASDAQ: SGMT) Trading Performance Indicators
Sagimet Biosciences Inc (SGMT) is currently performing well based on its current performance indicators. A quick ratio of 34.23 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.44, a number that is poised to hit -0.68 in the next quarter and is forecasted to reach -4.39 in one year’s time.
Technical Analysis of Sagimet Biosciences Inc (SGMT)
Compared to the last year’s volume of 0.84 million, its volume of 0.48 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 54.13%. Additionally, its Average True Range was 0.29.
During the past 100 days, Sagimet Biosciences Inc’s (SGMT) raw stochastic average was set at 7.79%, which indicates a significant decrease from 19.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 141.59% in the past 14 days, which was higher than the 117.27% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.59, while its 200-day Moving Average is $4.01. Nevertheless, the first resistance level for the watch stands at $2.30 in the near term. At $2.43, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.50. If the price goes on to break the first support level at $2.10, it is likely to go to the next support level at $2.03. Now, if the price goes above the second support level, the third support stands at $1.90.
Sagimet Biosciences Inc (NASDAQ: SGMT) Key Stats
Market capitalization of the company is 66.57 million based on 30,675K outstanding shares. Right now, sales total 0 K and income totals -45,570 K. The company made 0 K in profit during its latest quarter, and -16,200 K in sales during its previous quarter.
